Lurbinectedin in Patients With SCLC With Chemotherapy-Free Interval ≥30 Days and No CNS Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Lung Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lurbinectedin in patients with small cell lung cancer with chemotherapy-free interval ≥30 days and without central nervous metastases
Lung Cancer 2024 Feb 01;188(xx)107448, S Peters, J Trigo, B Besse, V Moreno, A Navarro, M Eugenia Olmedo, L Paz-Ares, C Grohé, J Antonio Lopez-Vilariño, C Fernández, C Kahatt, V Alfaro, A Nieto, A Zeaiter, V SubbiahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.